Strong CD8+ T-cell responses against tumor-associated antigens prolong the recurrence-free interval after tumor treatment in patients with HCC.
Strong CD8+ T-cell responses against tumor-associated antigens prolong the recurrence-free interval after tumor treatment in patients with HCC.
复制标题
CD8 T 细胞针对肿瘤相关抗原的强烈反应可延长 HCC 患者肿瘤治疗后的无复发间隔。
作者：
Hiroishi;K.;Eguchi;J.;Baba;T.;他11名
